Smith & Nephew (LSE:SN, NYSE:SNN), the global medical technology business, announces the successful completion of its first Wound Care Academy for the Kingdom of Saudi Arabia. Led by experts from the University of Hertfordshire, UK, 28 healthcare professionals from the Kingdom attended the course.
The week long intensive course is a theoretical and practical based learning initiative that aims to enhance the wound care knowledge of local healthcare professionals. Since its launch in 1999 in South Africa, more than 1000 participants across the Middle East and Africa have benefited from this intensive training opportunity.
The Wound Care Academy is led by Madeleine Flanagan, a wound care specialist with 25 years' experience, with specialists hosting sessions on topics including diabetic foot ulcers, pressure ulcer prevention and treatment, negative pressure wound therapy, and surgical site infection. Participants also visited a local hospital for patient visits.
"Providing this high level educational initiative to Saudi Arabian healthcare professionals for the first time demonstrates Smith & Nephew's commitment to enhancing wound care knowledge in the Kingdom of Saudi Arabia,” said Basel AbouJalala, Head of the Technical Scientific Office in KSA. “Participants are committed to sharing their new knowledge with colleagues when returning to their hospitals and will benefit from the launch of local Wound Care Academy Network Meetings in the Kingdom aimed at providing a platform to share knowledge and best practices.”
Media Enquiries
Jane Lawlor
Smith & Nephew
+971 (4) 428 4868
Charles Reynolds, Corporate Communications
Smith & Nephew
+ 44 (0) 20 74017646
About Smith & Nephew
Smith & Nephew is a global medical technology business dedicated to helping healthcare professionals improve people's lives. With leadership positions in Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine and Trauma & Extremities, Smith & Nephew has around 15,000 employees and a presence in more than 100 countries. Annual sales in 2015 were more than $4.6 billion. Smith & Nephew is a member of the FTSE100 (LSE:SN, NYSE:SNN).
For more information about Smith & Nephew, please visit our website www.smith-nephew.com, follow @SmithNephewplc on Twitter or visit SmithNephewplc on Facebook.com.
Forward-looking Statements
This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith & Nephew, these factors include: economic and financial conditions in the markets we serve, especially those affecting health care providers, payers and customers; price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls or other problems with quality management systems or failure to comply with related regulations; litigation relating to patent or other claims; legal compliance risks and related investigative, remedial or enforcement actions; disruption to our supply chain or operations or those of our suppliers; competition for qualified personnel; strategic actions, including acquisitions and dispositions, our success in performing due diligence, valuing and integrating acquired businesses; disruption that may result from transactions or other changes we make in our business plans or organisation to adapt to market developments; and numerous other matters that affect us or our markets, including those of a political, economic, business, competitive or reputational nature. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20-F, for a discussion of certain of these factors. Any forward-looking statement is based on information available to Smith & Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith & Nephew are qualified by this caution. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith & Nephew's expectations